SCHEMBL19702020

SCHEMBL19702020

CC(C)c1cccc(N2CCC(N(C)C(=O)c3ccco3)CC2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 1/20 0.58
NOTUM Q6P988 1/20 0.50
PIK3CD O00329 1/20 0.47
OPRM1 P35372 6/20 0.46
MAPT P10636 2/20 0.42
USP2 O75604 1/20 0.42
TSHR P16473 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CXCR4 P61073 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
TMEM97 Q5BJF2 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM3 P20309 1/20 0.40
NPY5R Q15761 4/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19711237 0.86 CCR5 (0.53) CCR5NOTUMPIK3CDOPRM1MAPT
SCHEMBL19658404 0.82 NOTUM (0.58) CCR5NOTUMPIK3CDHRH3NPY5R
SCHEMBL19652215 0.81 NOTUM (0.57) CCR5NOTUMHRH3NPY5RCYP1A2
SCHEMBL19702022 0.78 NOTUM (0.54) CCR5NOTUMPIK3CDHRH3NPY5R
SCHEMBL19702023 0.76 NOTUM (0.49) CCR5NOTUMPIK3CDHRH3NPY5R
SCHEMBL19702028 0.75 NOTUM (0.62) CCR5NOTUMPIK3CDHRH3
SCHEMBL19702017 0.73 NOTUM (0.53) NOTUMPIK3CDHRH3NPY5R
SCHEMBL19702026 0.72 NOTUM (0.58) CCR5NOTUMPIK3CDHRH3NPY5R
SCHEMBL26816763 0.71 NOTUM (0.71) NOTUMHRH3ALDH1A1CYP1A2CYP3A4
SCHEMBL6506958 0.71 NOTUM (0.85) NOTUMMAPTUSP2HRH3CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170355707-A1 BICYCLIC HETEROARYL AMINE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2017-12-14 US disclosed
US-20170355707-A1 BICYCLIC HETEROARYL AMINE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2017-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170355707-A1 BICYCLIC HETEROARYL AMINE COMPOUNDS PIK3R3, JAK2, JAK3 CCR5 765/4885NOTUM 3221/4885PIK3CD 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.